Detection of Cryptosporidium parvum DNA in formed human feces by a sensitive PCR-based assay including uracil-N-glycosylase inactivation

被引:22
作者
Gobet, P
Buisson, JC
Vagner, O
Naciri, M
Grappin, M
Comparot, S
Harly, G
Aubert, D
Varga, I
Camerlynck, P
Bonnin, A
机构
[1] HOP BOCAGE, LAB PARASITOL & MYCOL, F-21034 DIJON, FRANCE
[2] HOP BOCAGE, SERV MALAD INFECT & TROP, F-21034 DIJON, FRANCE
[3] INRA TOURS, F-37380 NOUZILLY, FRANCE
[4] CTR HOSP BESANCON, LAB PARASITOL & MYCOL, BESANCON, FRANCE
[5] CTR HOP REIMS, LAB PARASITOL & MYCOL, REIMS, FRANCE
[6] LAB DEPT COTE DOR, DIJON, FRANCE
[7] UNIV VET SCI BUDAPEST, BUDAPEST, HUNGARY
关键词
D O I
10.1128/JCM.35.1.254-256.1997
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We developed a PCR-based method that can be used to identify Cryptosporidium parvum in human feces. Fecal oocysts were concentrated by centrifugation on a sodium chloride gradient and filtration on a nitrocellulose filter prior to DNA extraction and PCR amplification of a 452-bp C. parvum-specific DNA sequence with a protocol including dUTP and uracil-N-glycosylase. All samples obtained from naturally infected humans (n = 10), calves (n = 4), and goats (n = 2) were positive, A 100% detection rate was achieved with both formed and solid stools (n = 10) seeded with 1,000 C. parvum oocysts per g. Procedures based on stool concentration by a modified Ritchie method and subsequent oocyst identification by immunofluorescent labeling or acid-fast staining require concentrations of 50,000 to 500,000 oocysts per g to achieve a 100% detection rate with formed stools. The described PCR-based assay thus has a 50- to 500-fold increase in sensitivity compared to those of the methods commonly used to analyze formed feces.
引用
收藏
页码:254 / 256
页数:3
相关论文
共 27 条
[1]   DETECTION OF CRYPTOSPORIDIUM-PARVUM OOCYSTS IN BOVINE FECES BY MONOCLONAL-ANTIBODY CAPTURE ENZYME-LINKED-IMMUNOSORBENT-ASSAY [J].
ANUSZ, KZ ;
MASON, PH ;
RIGGS, MW ;
PERRYMAN, LE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (12) :2770-2774
[2]   Detection of Cryptosporidium parvum DNA in human feces by nested PCR [J].
Balatbat, AB ;
Jordan, GW ;
Tang, YJ ;
Silva, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (07) :1769-1772
[3]   PAROMOMYCIN - AN EFFECTIVE TREATMENT FOR CRYPTOSPORIDIAL DIARRHEA IN PATIENTS WITH AIDS [J].
BISSUEL, F ;
COTTE, L ;
RABODONIRINA, M ;
ROUGIER, P ;
PIENS, MA ;
TREPO, C .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (03) :447-449
[4]  
Bonnin A, 1996, FEMS MICROBIOL LETT, V137, P207, DOI 10.1016/0378-1097(96)00056-0
[5]   CHARACTERIZATION OF MICRONEME ANTIGENS OF CRYPTOSPORIDIUM-PARVUM (PROTOZOA, APICOMPLEXA) [J].
BONNIN, A ;
DUBREMETZ, JF ;
CAMERLYNCK, P .
INFECTION AND IMMUNITY, 1991, 59 (05) :1703-1708
[6]   EPIDEMIOLOGIC ASPECTS OF HUMAN CRYPTOSPORIDIOSIS [J].
CASEMORE, DP .
EPIDEMIOLOGY AND INFECTION, 1990, 104 (01) :1-28
[7]   Cryptosporidium parvum: Intensity of infection and oocyst excretion patterns in healthy volunteers [J].
Chappell, CL ;
Okhuysen, PC ;
Sterling, CR ;
DuPont, HL .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (01) :232-236
[8]  
CLEZY K, 1991, AIDS, V5, P1146, DOI 10.1097/00002030-199109000-00020
[9]   HUMAN CRYPTOSPORIDIOSIS [J].
CRAWFORD, FG ;
VERMUND, SH .
CRC CRITICAL REVIEWS IN MICROBIOLOGY, 1988, 16 (02) :113-159
[10]   USE OF PAROMOMYCIN FOR TREATMENT OF CRYPTOSPORIDIOSIS IN PATIENTS WITH AIDS [J].
FICHTENBAUM, CJ ;
RITCHIE, DJ ;
POWDERLY, WG .
CLINICAL INFECTIOUS DISEASES, 1993, 16 (02) :298-300